Editorial Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/anesthesia.1.005
Etrasimod: A promising therapeutic candidate against Multiple Sclerosis
Simranjeet Kaur1, Amandeep Singh2, Rohit Bhatia3,*
- 1Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Jhande, VPO Baddowal, Ludhiana, Punjab, India
- 2Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India
- 3Department of Pharmaceutical Chemistry, 1, Moga-142001, Punjab, India
Corresponding Author
Rohit Bhatia, bhatiarohit5678@gmail.com
Received Date: April 10, 2020
Accepted Date: May 08, 2020
Kaur S, Singh A, Bhatia R. Etrasimod: A promising therapeutic candidate against Multiple Sclerosis. J Clin Anesth Intensive Care. 2020; 1(1): 17-19.
Copyright: © 2020 Kaur S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Etrasimod: A promising therapeutic candidate against Multiple Sclerosis
Multiple sclerosis (MS) is central nervous system (CNS) based disease. It is a chronic inflammatory demyelinating disease [1]. The main causes for MS are genetic and environmental factors. It is a disease of young people (median age of onset is around 28 years) but is lifetime and is often disabling; 50% of patients need a cane to walk 15 years after disease onset; and Worldwide more than 2.5 Million persons are affected.
Oligodendrocyte regulation of synaptogenesis may contribute to epilepsy development both in multiple sclerosis and polymicrogyria
CNS myelination is a well-known biological phenomenon related to increase in action potential conduction speed and synaptic integration. Demyelination or abnormal myelination has been related to seizures and epilepsy either in patients or animal models. Although its role in fastening action potential propagation has been confirmed, few additional biological functions of CNS myelin has been described.
Friend or foe? The elusive role of ANGPTL4 in inflammation
Angiopoietin-like 4 (ANGPTL4) is a multifaceted secreted protein discovered by three different institutions in 2000 simultaneously [1]. It is expressed in adipose tissues, liver, muscle, heart, kidney, skin, and other tissues. The nutritional, metabolic, and inflammatory status of the organism regulate the expression of ANGPTL4 [2-4].
An essential role for hepatocyte adenosine kinase in regulating fat metabolism and inflammation
Metabolic dysfunction-associated steatotic liver disease (MASLD) is comprised of a spectrum of conditions, which is a progressive form of liver disease ranging from simple steatosis to steatohepatitis. The liver regulates fat metabolic homeostasis through de novo lipogenesis, fatty acid uptake and oxidation, low-density lipoprotein secretion in hepatocytes.
Coloring outside the lines: Exploring the dysbiotic impact of azo dyes on gut health and inflammation
Beyond mere aesthetics, the vibrant hues of fruits, vegetables, and culinary creations evoke sensory experiences that influence perceptions of flavor, freshness, and even nutritional value. This concept highlighted the pivotal role that color can play in the realm of food, serving as a powerful tool to captivate consumers and entice their taste buds.